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Summary
The precise control of the cell cycle requires regula-
tion by many intrinsic and extrinsic factors. Whether
the metabolic status of the cell exerts a direct control
over cell cycle checkpoints is not well understood.
We isolated a mutation, tenured (tend ), in a gene en-
coding cytochrome oxidase subunit Va. This mutation
causes a drop in intracellular ATP to levels sufficient
to maintain cell survival, growth, and differentiation,
but not to enable progression through the cell cycle.
Analysis of this gene in vivo and in cell lines shows
that a specific pathway involving AMPK and p53 is ac-
tivated that causes elimination of Cyclin E, resulting in
cell cycle arrest. We demonstrate that in multiple tis-
sues the mitochondrion has a direct and specific role
in enforcing a G1-S cell cycle checkpoint during peri-
ods of energy deprivation.
Introduction
Cell cycle progression from one phase to the next is in-
tricately controlled and is regulated by many check-
points that respond to intrinsic and extrinsic signals.
During the G1 phase, the cell integrates mitogenic and
growth inhibitory signals and makes the decision to pro-
ceed, pause, or exit the cell cycle (Johnson and Walker,
1999). The core cell cycle machinery is composed of Cy-
clins and Cyclin-dependent kinases (CDKs), which are
assembled and degraded during the course of cell divi-
sion. Distinct Cyclins associate with and activate differ-
ent CDKs throughout the cell cycle. For example, mam-
malian D-cyclins bind CDK4/6 to link external signals
to the cell cycle and regulate progression through G1
(Weinberg, 1996). In contrast, Drosophila Cyclin D con-
trols growth (Datar et al., 2000), whereas the G1-S tran-
sition is primarily controlled by Cyclin E (Richardson
et al., 1993). Drosophila Cyclin E function requires it to
bind to Cdc2c (similar to mammalian CDK2) in late G1.
Later in the cell cycle, Cyclins A and B complex with
CDK1 and are important for the G2-M transition; their
subsequent degradation is critical for exit from mitosis.
The activity of Cyclin/CDK complexes is modulated by
both activating and inhibitory phosphorylation of the
CDK protein. The inhibitors INK4 and the CIP/KIP family
of proteins are required for downregulation of the Cyclin/
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2 These authors contributed equally to this work.CDK complexes. In multicellular eukaryotes, stimuli in-
cluding growth factors such as insulin (Bohni et al.,
1999), TGFb (Shi and Massague, 2003), Wnts (Nusse and
Varmus, 1982), Hedgehog (reviewed by Ho and Scott,
2002), EGFR ligands (Lui and Grandis, 2002), and cell ad-
hesion molecules (Lee and Juliano, 2004) can each act
through signaling pathways to alter cell cycle progres-
sion. Similarly, environmental conditions such as nu-
trients and oxygen levels can also control the cell cycle
(Carmeliet et al., 1998). In addition, intrinsic cellular com-
ponents including oncogenes such as Myc (reviewed by
Bouchard et al., 1998) and Ras (reviewed by Kerkhoff and
Rapp, 1998), tumor suppressors like Tsc (Ito and Rubin,
1999; Potter et al., 2001; Tapon et al., 2001) and p53
(Vousden and Lu, 2002), microRNAs like bantam (Bren-
necke et al., 2003) and Sterile-20 kinases such as Slik
(Hipfner and Cohen, 2003) and Hippo (Harvey et al.,
2003; Udan et al., 2003; Wu et al., 2003) modulate the
cell cycle.
The two components of the cell cycle, growth (in-
crease in cell mass) and proliferation (increase in cell
number), were initially viewed as aspects of a single pro-
cess. However, molecular pathways controlling growth
and proliferation can be separable. Mutations that block
cell proliferation often do not block growth, while some
cells can grow without dividing (reviewed in Edgar and
Lehner, 1996; Schmelzle and Hall, 2000; Su and O’Farrell,
1998). The target of rapamycin protein (TOR) is an evolu-
tionarily conserved serine/threonine kinase that has
been shown to couple nutrients with growth factors
(Shamji et al., 2003). Thus, TOR can be considered to
act as a growth ‘‘rheostat’’ that helps in gauging nutrient
levels and environmental stimuli, thereby regulating cell
growth (Fingar and Blenis, 2004).
In early studies, Holley and Kiernan (1974) showed
that low glucose levels can arrest 3T3 cells primarily in
the G1 phase. Similarly, Drosophila cells arrest in inter-
phase and metaphase when embryos are treated with
cyanide, an inhibitor of oxidative phosphorylation, or
when they are maintained under hypoxic conditions (Di-
Gregorio et al., 2001). The mechanisms underlying these
effects were poorly understood. In this paper, we show
a link between mitochondrial function and the regulation
of Cyclin E, and we provide evidence for a specific cell
cycle checkpoint that senses the metabolic status of
the cell.
Cellular energy is largely derived from the process of
oxidative phosphorylation in the mitochondrion. The
status of cellular energy stores is computed by AMP-
activated protein kinase (AMPK). The heterotrimeric
AMPK protein comprises a catalytic a subunit and regu-
latory b and g subunits (Carling, 2004). AMP binds to the
g subunit of AMPK and allosterically promotes the phos-
phorylation of a critical threonine residue of AMPKa by
AMPK kinase (Hawley et al., 1995). Cellular stresses that
deplete ATP cause a rise in AMP levels, resulting in the
activation of AMPK (Hardie, 2005). In a recent paper,
Jones et al. (2005) showed that glucose limitation in
mouse embryonic fibroblasts can cause phosphoryla-
tion of AMPK and activation of p53, a key mediator of
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844Figure 1. tend Larval and Adult Phenotypes
(A) BrdU incorporation (red) in a wild-type third instar larval eye
imaginal disc. The dotted arrow marks the morphogenetic furrow
(MF). Random BrdU incorporation is seen anterior to the MF (arrow-
heads). A single band of BrdU incorporation marking the initiation of
the second mitotic wave is evident posterior to the furrow (arrow).
BrdU was incorporated for 30 min; posterior is to the left.
(B–D) Eyes of adult flies. (B) Scanning electron micrograph (SEM) of
a wild-type eye. (C) Somatic clones of tend shown in bright field. The
mutant tissue is white and glossy, while wild-type tissue is red and
faceted. (D) SEM of the same eye shown in (C). Facets are identifi-
able in the wild-type tissue, while the mutant tissue appears smooth
due to lack of lenses. This phenotype is characteristic of loss of lens
secreting cone and pigment cells that develop late and are derived
from the cells that divide during the second mitotic wave.
(E–G) 30 min BrdU incorporation (red) in late third instar larval eye
discs. Atonal (blue) marks the furrow. (E) In a control eye disc in
which both green and non-green cells are wild-type, BrdU incorpo-
ration is normal (as in [A]). (F and G) In two examples in which the
non-green tissue is tend2/tend2 and the green tissue is wild-type,
BrdU incorporation is affected in the mutant tissue both anterior
and posterior to the furrow. Some incorporation of BrdU in mutant
tissue immediately adjacent to wild-type is indicated (arrows; see
text for details). Posterior is to the left.
(H–J) BrdU incorporation (red) in early larval development in tend
mutant clones (absence of green). In (H) second, (I) early third, andthe cellular response to genotoxic stress and best
known for its regulation of cell cycle checkpoints and
apoptosis in response to irradiation (reviewed by West-
phal, 1997).
In this paper, we report that mutations in several mito-
chondrial proteins cause a cell cycle arrest late during
larval growth in Drosophila. We describe the mechanis-
tic basis for this arrest for a mutation in cytochrome
oxidase Va. Although it seems intuitive that energy levels
should dictate the course of cell proliferation, the mech-
anism underlying this phenomenon was essentially
unclear. It was also unclear if this process was simply
due to the general slowdown of all cellular processes
or whether it was due to the activation of a specific path-
way in cell cycle regulation. In this paper, we describe
how tissues in vivo respond to low ATP levels, through
the activation of a Cyclin E-mediated cell cycle check-
point leading to arrest in the G1 phase without affecting
cellular differentiation and cell viability.
Results
Cell Cycle Progression Is Affected in tenured Mutant
Clones
In the developing third instar wild-type eye disc, cell fate
specification and patterning events sweep as a wave
across the eye field, from the posterior to the anterior.
The leading edge of the wave of differentiation is marked
by an indentation, the morphogenetic furrow (MF). Two
distinct phases of cell proliferation have been identified
with respect to the furrow (Wolff and Ready, 1991). An-
terior to the MF, BrdU incorporation is seen in randomly
distributed cells (Figure 1A). This is followed by a G1 ar-
rest of cells within the furrow, and a synchronous band
of BrdU-positive cells can be seen immediately poste-
rior to the furrow marking the initiation of the so-called
second mitotic wave (SMW) (Figure 1A). In a flp/FRT-
based mitotic recombination screen (Newsome et al.,
2000), for mutations that give rise to a ‘‘glossy’’ adult
eye phenotype (Figures 1B–1D), we identified a homozy-
gous lethal mutation that causes a significant alteration
in the BrdU incorporation pattern in the developing third
(J) mid third instar larval eye discs, extensive BrdU incorporation
is evident in mutant clones.
(K) Prolonged (120 min) incorporation of BrdU in tend clones (ab-
sence of green). The furrow is marked with Armadillo (blue). Asyn-
chronous BrdU incorporation anterior to the MF recovers in mutant
tissue (arrowheads). However, cells fail to exit G1 arrest posterior to
the furrow (arrow; compare BrdU [in red] with [E]).
(L–M) BrdU incorporation (red) is defective in tend clones (arrows)
generated by hsp70-flp in (L) eye and in (M) wing imaginal discs of
late third instar larvae. Small clones (asterisks) show normal BrdU in-
corporation (see text for details).
(N–O) Flow cytometric analysis of dissociated wing imaginal discs
containing tend clones. Clones were generated by hsp70-flp 48 hr
after egg deposition, and the discs were dissociated 72 hr thereafter.
tend2/tend2 cells (non-green) are distinguishable in these assays
from wild-type (GFP-positive and green). (N) A DNA profile of tend
mutant cells (blue tracing), and that of wild-type cells (red tracing),
indicates that a greater proportion of tend cells are in G1 (2C) com-
pared to wild-type. (O) Cell size measured by flow cytometry. The
wild-type population (in red) and the mutant population (in blue)
are shown. Comparison of forward scatter count (FSC) values sug-
gests that the mean size of mutant cells is approximately 13% larger
than wild-type.
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clones are easily recoverable, implying that mutant cells
have divided to generate them, mutant clones both an-
terior to the furrow and along the SMW fail to incorporate
BrdU. The large clone size suggests that mutant cells
must have divided earlier in development. Consistent
with this notion, we found that BrdU incorporation is
normal in homozygous mutant clones from late second
instar and early third instar eye discs (Figures 1H–1J).
In these experiments, BrdU was incorporated for 30 min.
Upon prolonged BrdU incorporation, over 120 min,
which allows for the detection of a slower entry into S
phase (Tapon et al., 2001), BrdU incorporation is seen
in mutant cells anterior to the furrow, but not along the
SMW of third instar larval eye discs (Figure 1K). These
results show that mutant cells can proliferate normally
during the first several rounds of cell division in early lar-
val instars, slow down their S phase later in the third in-
star, and eventually fail to enter S phase after G1 arrest in
the MF. We termed this mutation tenured (tend).
The clones shown in Figures 1E–1K were generated
with ey-flp. In this genetic background, the flpgene is ex-
pressed under the control of the eyeless (ey) enhancer,
and the expressed Flp protein can potentially create re-
combination events and mutant clones in the eye
throughout the early larval stages. Mutant clones were
also generated in both eye and wing discs by using
hsp70-flp, and flp was expressed only during the brief
single heat pulse 48 hr after egg laying. BrdU incorpora-
tion is defective in such clones as well, both in eye and
wing discs (Figures 1L and 1M), establishing that the
cell cycle defect is not tissue specific. Wing discs
containing clones were dissociated with trypsin to yield
individual cells that were stained with Hoechst dye and
analyzed by flow cytometry for cell cycle phasing. Com-
pared with GFP-positive heterozygous cells, a greater
fraction of tend2/tend2 cells are in the G1 phase of the
cell cycle (Figure 1N). These findings in wing discs are
consistent with the genetic results from the eye disc in
which the mutant cells are held in G1. Furthermore, anal-
ysis of the average cell size, as gauged by forward scat-
ter, shows that tend cells are about 13% larger than their
wild-type neighbors (Figure 1O). These results indicate
that, in tend clones, proliferation is affected without ad-
versely affecting cell size.
Molecular Characterization of tend
The tend lethality was mapped by using deficiencies to
the region between 86F6 and 86F9 on the right arm of
the third chromosome (Figure 2A). The eye phenotype
associated with this mutation was also independently
mapped to this region by recombination mapping (see
Experimental Procedures for details). Upon sequencing
all of the ORFs in this region, we found a 56 base pair de-
letion in the gene encoding cytochrome c oxidase sub-
unit Va (CoVa). CoVa is a small regulatory subunit of cy-
tochrome c oxidase (Complex IV), which functions in the
terminal step of the mitochondrial electron transport
pathway. The 56 base pair deletion creates a null allele
for the gene encoding CoVa; the resulting frame shift al-
ters every functional amino acid and terminates prema-
turely within the mitochondrial leader sequence. The ge-
nomic region including the CoVa coding region and 500
bp each of upstream and downstream flanking DNA wasused to generate transgenic flies. The lethality and eye
phenotypes associated with the tendmutation were res-
cued in these transgenic flies (Figures 2B–2D). We con-
clude that tend represents a null allele for the gene en-
coding cytochrome c oxidase subunit Va (CoVa).
Somatic mutant clones of available recessive lethal
mutations in additional mitochondrial genes were tested
for their eye phenotype. Mutations in PdsW, a protein in-
volved in the function of Complex I of the electron trans-
port chain, and mitochondrial ribosomal proteins
mRpL17 and mRpL4 give rise to a glossy eye phenotype
similar to that seen for tend (example shown in Figures
2E and 2F). The similarity is also evident in eye disc
clones in which BrdU incorporation is found to be defec-
tive (Figure 2G). Therefore, the transition from G1 to S
phase of the cell cycle can be altered upon a reduction
Figure 2. tend Is a Mutation in the Gene Encoding Subunit Va of
Cytochrome c Oxidase
(A) Organization of genes (based on Flybase annotation) in the 86F7–
86F10 region. The lethality of tend fails to complement lethality of
flies deleted for the regions marked in red and complements those
shown in green. By meiotic recombination, the eye phenotype was
mapped to the right of P13434. The 56 bp deletion in tend is shown
in relation to the translational start and stop sites. The genomic frag-
ment used for transformation and rescue of the eye phenotype and
lethality of tend is shown in blue.
(B–F) Eyes of adult flies. (B) Somatic clones of tend (white) appear
smooth and glossy, and the wild-type tissue (red) shows normal fac-
ets. (C and D) tend2/tend2 clones were generated as in (B), but in
a fly transformed with the genomic region shown as the blue line
in (A). The mutant adult eye phenotype associated with tend is com-
pletely rescued, as seen in (C) bright field and (D) SEM images. (E
and F) Somatic clones of mRpL4 shown in (E) bright field and (F)
SEM. The adult eye phenotype is similar to that seen for tend (com-
pare with [B] and also Figures 1C and 1D).
(G) Third instar eye disc with clones of mRpL4 (absence of green).
The furrow is marked with Armadillo (blue). BrdU incorporation is de-
fective in the clones both anterior and posterior to the MF, similar to
that seen for tend (compare with Figures 1F and 1G).
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tein in tend Mutants
(A–G0 0) Expression of cell cycle regulators
(red) in (A–G) wild-type and in (A0–G0) tend
mutant clones shown as a merge (absence
of green). For clarity, the red channel in (A0)–
(G0) is also shown separately in grayscale in
(A0 0)–(G0 0). All panels show the region adjacent
to the furrow (marked in blue in [A]/[A0], [B]/
[B0], and [D]/[D0]) of late third instar eye discs.
Posterior is to the left. (A–A0 0) Cyclin A, (B–B0 0)
Cyclin B, (C–C0 0) Cyclin D, (D–D0 0) Ci, and (E–
E0 0) Dacapo are expressed normally in tend
clones. (F and G) Wild-type expression of Cy-
clin E as a band posterior to the furrow by us-
ing independent antibodies againstDrosoph-
ila Cyclin E raised in guinea pig and rat. (F0
and G0) Cyclin E expression is reduced in
tend clones (absence of green). (F0 0 and G0 0)
The red channel from (F0) and (G0) is shown
again in grayscale for clarity. Arrows mark
wild-type tissue that expresses Cyclin E.
(H and H0) Cyclin E RNA detected by in situ
hybridization in eye discs. Posterior is to the
left. (H) Cyclin E transcript in a wild-type eye
disc. (H0) Cyclin E transcript is unaffected in
a disc with clones of tend. Seven eye discs
were analyzed under conditions under which
independent staining showed that large mu-
tant clones are present in every single disc
(as shown in [F0] and [G0]).
(I and J) Rescue of BrdU incorporation in tend
discs by overexpression of Cyclin E. (I) BrdU
incorporation in sibling control discs that
did not carry hs-Cyclin E. Third instar larvae
were heat shocked for 90 min, followed by
a 120 min recovery period. BrdU incorpora-
tion was then carried out for 120 min. Note
that the band of incorporation behind the fur-
row is missing (marked by an arrow) in the
clones, which is also described in Figure 1K.
(J) BrdU incorporation was carried out after
heat shock in tend discs carrying hs-Cyclin
E as described for (I). The second mitotic
wave of BrdU incorporation (marked by an ar-
row) recovers in mutant clones upon overex-
pression of Cyclin E.of the mitochondrial function seen for mutations in one
of several nuclear genes that encode mitochondrial
proteins.
tendMutant Cells Show a Marked Decrease in Cyclin
E Protein Levels
To determine the molecular basis of the tend cell cycle
defect, we analyzed the expression of Cyclins and
Cyclin-associated proteins in mutant clones. Cyclin A
and Cyclin B, essential for the G2-M transition, are ex-
pressed normally in tend mutant clones (Figures 3A–A0 0
and 3B–3B0 0). The expression of Cyclin D, one of the pri-
mary G1-cyclins is also unaffected (Figures 3C–C0 0).
Likewise, the expression of Ci, a known inducer of Cyclin
E expression (Duman-Scheel et al., 2002), is normal (Fig-
ures 3D–D0 0). No upregulation in the expression patternof the only known Drosophila CDK inhibitor, Dacapo, is
evident in the mutant clones (Figures 3E–E0 0). In contrast,
the level of Cyclin E protein is considerably reduced in
tend clones. Cyclin E expression in wild-type eye discs
is seen as a narrow stripe immediately posterior to the
MF (Figures 3F and 3G). In comparison, tend mutant
cells show a significant reduction in Cyclin E protein.
Two independently isolated antibodies against Cyclin
E were used to confirm these results (Figures 3F0, 3F0 0,
3G0, and 3G0 0). Loss of Cyclin E expression in tend mu-
tant clones is not regulated at the transcriptional level,
as the Cyclin E transcript is expressed normally in mu-
tant clones (Figures 3H and H0). Hence, the loss of Cyclin
E in tendmutants is due to a decrease in Cyclin E protein
translation, stability, or both. The G1-S block seen in the
second mitotic wave in tend mutant clones is rescued
Mitochondrial Regulation of Cell Cycle Progression
847Figure 4. Patterning, Apoptosis, and Mor-
phogenesis in tend Mutant Clones
(A–F0) Third instar larval eye discs with so-
matic clones (absence of green) stained
with antibodies (red) against (A and A0)
Atonal, (B and B0) ELAV, (C and C0) Lozenge,
(D and D0) BarH1, (E and E0) Cut, or for (F
and F0) TUNEL. In all cases, posterior is to
the left. (A–F) Mock clones in which green
and non-green tissue are both wild-type.
(A0–F0) tend mutant clones are not green,
while wild-type cells are green. Expression
of Atonal, ELAV, Lozenge and BarH1, is nor-
mal in tend mutant clones, except for minor
perturbations of the ordered array. Fewer
Cut-positive cells are seen in the mutant tis-
sue, and the number of TUNEL-positive cells
is unaffected in the mutant.
(G) R cell axon projections in the optic lobe.
mAb24B10 staining (red) was used to high-
light cell bodies and axons of differentiating
neurons. Cells within tend clones (absence
of green) in the eye disc (ed) are capable of
sending axonal projections into the lamina
(lm) and medulla (me) of the optic lobe (op)
in the brain.upon overexpression of Cyclin E by using a hsp70 driver
(Figure 3J). This further demonstrates that the prolifera-
tion phenotype is due to the downregulation of Cyclin E
in mutant clones.
Morphogenesis and Differentiation Are Largely
Unaffected in tend Clones
Patterning events of differentiation and morphogenesis
remain relatively normal in tendmutant clones (Figure 4).
Photoreceptor (R) cell cluster formation is initiated with
the expression of Atonal (Figures 4A and A0), and all dif-
ferentiating neurons posterior to the furrow express
ELAV (Figures 4B and B0). Only modest perturbation of
spacing and orientation of the clusters is evident. The
transcription factor Lozenge is also normally expressed
in all undifferentiated mutant cells posterior to the fur-
row (Figures 4C and C0). Later recruitment of R1 and
R6 cells is also normal, as evidenced by their expression
of BarH1 (Figures 4D and D0). Importantly, tend mutant
neurons not only express the neuronal markers, but
they are also fully capable of undergoing major morpho-
logical changes such as extending their axonal projec-
tion to the optic center of the brain (Figure 4G). Cone
cells expressing Cut are also seen (Figures 4E and E0),
but their numbers are reduced, a likely contributing fac-
tor to the glossy adult eye phenotype. Finally, no change
in numbers of TUNEL-positive cells is evident within the
mutant clones, establishing that tend mutant cells do
not show an increase in apoptosis in third instar mutant
clones (Figures 4F and F0).
In conclusion, tenured cells are held in the G1 phase of
the cell cycle, but they do not apoptose, can receive de-
velopmental signals, can differentiate into neuronal and
nonneuronal cell types, and undergo major morpholog-
ical changes such as extension of axons. With the nota-
ble exception of Cyclin E, expression of major cell cycle
regulators also remains normal. We interpret these re-
sults to mean that the loss of mitochondrial function in
the tend mutant does not cause a nonspecific blockagein all cellular functions; rather, it causes a specific block
in cell cycle progression at the level of Cyclin E protein
regulation.
tend Mutant Cells are Underrepresented
In order to generate the large tend2/tend2 mutant
clones shown in Figure 1, we used the convenient
Minute (M) genetic background. The M+tend2 cells are
afforded an unfair growth advantage over their slow-
growing M2tend+ neighbors. How would tend2/tend2
cells perform in their proliferation function when com-
pared against cells that are completely wild-type? To
address this issue, we generated tend mutant clones
in a wild-type background and compared the number
of cells in mutant clones (tend2/tend2) with their corre-
sponding twin spots (tend+/tend+). Control clones gen-
erated with the wild-type parent FRT82B chromosome
are indistinguishable in size from the corresponding
twin spot irrespective of the size of the individual clones
(Figure 5A). Analysis of tend2/tend2 clones and their
wild-type twin spots revealed that they are similar in
size when relatively small; however, as the clone size in-
creases, the number of cells in a tend clone is far re-
duced compared to that in its sister twin spot
(Figure 5B). The fact that the first few cell divisions in
mutant clones of tend are normal is also consistent
with the observation that small mutant clones of tend
do not show the BrdU incorporation defect seen in large
clones (marked by asterisks in Figures 1L and 1M). Thus,
tenured cells can divide normally for 2–3 rounds of the
cell cycle but then start to slow down, while their wild-
type counterparts proceed through additional cell divi-
sions. Newly derived mutant cells could have many
more wild-type mitochondria or perdurant CoVa protein
as compared to cells derived from later divisions. In fact,
closer inspection of ey-flp-generated large clones
shows BrdU-positive cells along the edges of the mutant
tissue (Figures 1F and 1G). As ey is expressed continu-
ously in the eye disc, one explanation for this apparent
Developmental Cell
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on Clonal Cell Number
(A and B) The number of cells in mock wild-
type (absence of green in the inset of [A]) or
tend mutants (absence of green in the inset
of [B]) were compared with their correspond-
ing twin spots (bright green in the insets of [A]
and [B]). Nuclei marked with To-pro-3 (blue)
were counted to determine cell number. The
results are displayed as histograms for 24 in-
dependently identified clones. (A) Clones of
a wild-type parent chromosome (GFP2/
GFP2, white bars) and their corresponding
twin spots (GFP+/GFP+, black bars) are iden-
tical in size to one another irrespective of the
number of cells in the clone. (B) Clones of
tend2/tend2 cells (also GFP2/GFP2, white
bars) compared with their corresponding
twin spots (GFP+/GFP+, black bars). Small
mutant clones are comparable in size to the
wild-type twin spot, but large mutant clones
are outcompeted by wild-type.nonautonomy is that these mutant cells are recently de-
rived in late divisions from the adjacent wild-type tissue.
An alternate explanation of this apparent nonautonomy
is that wild-type cells are able to rescue their mutant
neighbors by a currently unknown mechanism. How-
ever, the first explanation is more likely since this effect
is much reduced when clones are generated with hsp70-
flp activated with a single pulse of heat shock (Figures
1L and 1M).
Proliferation in CoVa-Depleted Cells Correlates
with Reduced Levels of ATP
To assess ATP levels in CoVa-depleted cells,Drosophila
S2 cells were treated with CoVa dsRNA (Figure 6A) or
with GST dsRNA (as an experimental control). The level
of cellular ATP was measured in days after the dsRNA
treatment. In Figure 6B, the ATP level in cells treated
with CoVa dsRNA is normalized to that seen in GST
dsRNA-treated cells. Two days after treatment, the cel-
lular ATP level inCoVa dsRNA-treated cells is essentially
identical to that in cells treated with GST dsRNA. Begin-
ning on the third day, however, a gradual decrease in the
ATP level is seen in CoVa dsRNA-treated cells, and it
reaches a steady state of 43% of the control cells by
the seventh day (Figure 6B).
Proliferation of CoVa dsRNA-treated cells correlates
well with the gradual reduction of ATP (Figures 6C and
6D). On the first two days, CoVa dsRNA-treated cells
grow on par with control cell populations. Thereafter, af-
ter an estimated four rounds of doubling, cells treated
with CoVa dsRNA attenuate their rate of cell division
and reach a plateau after the sixth day. The failure of
the CoVa dsRNA-treated cells to undergo proliferationis due to significant reduction in the level of Cyclin E pro-
tein in these cells (Figure 6E). However, no reduction in
the level of Cyclin E transcripts is found in CoVa
dsRNA-treated cells (Figure 6F). The expression of the
other G1-cyclin, Cyclin D, is also normal in these cells
(Figure 6E). Trypan Blue staining confirmed that CoVa
dsRNA-treated cells remain fully viable 8 days after treat-
ment, when the final ATP and proliferation measure-
ments are made. The number of cells that exclude Try-
pan Blue on the eighth day is similar for both GST
dsRNA-treated cells (97.1% n = 1000) and cells treated
with CoVa dsRNA (97.5% n = 1000). These observations
are completely consistent with results from in vivo clones
of tend mutant cells and show once again that the block
in cell division is due to a specific regulation of the Cyclin
E protein. Also, as for the in vivo results, these G1-
arrested cells do not apoptose. Finally, the cell culture
experiments provide a direct correlation between cellu-
lar ATP levels, proliferation, and CoVa function.
A Pathway for Cyclin E Control by ATP Levels
Previous studies have suggested that AMP-activated
protein kinase (AMPK) can function as a sensor for cel-
lular energy levels (reviewed by Hardie, 2004). We there-
fore measured total and phosphorylated (active) AMPK
in CoVa dsRNA-treated cells. The level of phosphory-
lated AMPK rises as intracellular ATP drops in CoVa-
depleted cells (Figure 6G). Therefore, loss of mitochon-
drial function and reduced ATP in S2 cells causes AMPK
activation. The role of AMPK in this process was then
tested in vivo. Drosophila SNF4g encodes the AMP-
sensing g subunit of AMPK. Adult eyes of flies with
clones of SNF4g are wild-type (Figures 6H–6I0). The
Mitochondrial Regulation of Cell Cycle Progression
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Cells Depleted of CoVa
(A) S2 cells were treated with either GST or
CoVa dsRNA, and the levels of CoVa and dor-
sal (as an unrelated control) transcripts were
measured 2 days later by RT-PCR. Cells
marked ‘‘Control’’ were not treated with any
dsRNA. CoVa dsRNA causes a specific deg-
radation of CoVa RNA.
(B) S2 cells were treated with GST (control) or
CoVa dsRNA, and the cellular ATP level was
measured by a luciferin-luciferase assay in
the days after dsRNA treatment. The normal-
ized ATP levels in CoVa dsRNA-treated cells
as indicated along the ordinate are plotted
as a function of days.
(C) Proliferation profile of untreated S2 cells
(blue) and those treated with GST dsRNA
(green) or CoVa dsRNA (red). After initial
rounds of mitosis, CoVa dsRNA-treated cells
slow down and stop dividing.
(D) S2 cells were either untreated (control) or
treated with GST dsRNA or CoVa dsRNA as
indicated. The cells shown were photo-
graphed 8 days after dsRNA treatment.
(E) Western blot analysis performed 7 days
after treatment of S2 cells with GST dsRNA
(lane 1) or CoVa dsRNA (lane 2) by using indi-
cated antibodies. Cyclin D expression is
comparable in both lanes, but Cyclin E is dra-
matically reduced in CoVa dsRNA-treated
cells. Actin was used as a loading control.
(F) RT-PCR analysis of indicated transcripts 7
days after treatment of S2 cells with GST
dsRNA (lane 1) orCoVadsRNA (lane 2). Unlike
the loss of Cyclin E protein seen in (E), Cyclin
E RNA levels remain unchanged. rp49 was
used as a control. M, marker lane.
(G) Western blot analysis of GST (control) or
CoVa dsRNA-treated cells with antibodies
against total (a-AMPK) and activated AMPK
(a-pAMPK). In both control and experimental
samples, the total AMPK level remains un-
changed. However, pAMPK rises in CoVa
dsRNA-treated cells, but not in the control.
Actin was used as a loading control.
(H–K0) SEM of adult eyes. (H and H0) Wild-type
facets shown in (H) low and (H0) high magnifi-
cation. (I and I0) SNF4g clones are wild-type.
(J and J0) Clones of tend appear smooth.
‘‘WT’’ marks wild-type, and ‘‘M’’ marks mu-
tant tissue shown in higher magnification in
(J0). (K and K0) The smooth eye phenotype of
tend clones is partially rescued in double mu-
tant clones of tend and SNF4g. The double
mutant tissue is shown in higher magnifica-
tion in (K0) (compare with [J0]).
(L) BrdU incorporation (red) in eye discs with
double mutant clones of tend and SNF4g (ab-
sence of green). A remarkable recovery of
BrdU incorporation to virtually wild-type lev-
els is seen in these clones (compare with Fig-
ures 1F and 1G).
(M) In double mutant clones of tend and
SNF4g, Cyclin E (red) expression recovers
to wild-type levels.
(N) Normal BrdU incorporation (red) is seen in
somatic clones of dTOR (absence of green).tend mutation was recombined with the mutation in
SNF4g, and double mutant clones were generated in
the eye. The adult eye of the double mutant for tend
and SNF4g contains many more facets (Figures 6Kand 6K0) than is seen in tend mutant clones (Figures 6J
and 6J0). Additionally, BrdU incorporation and Cyclin E
expression is restored to normal in double mutant eye
disc clones (Figures 6L and 6M). This implies that the
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850Figure 7. Function of p53 Downstream of
AMPK
(A) S2 cells were either treated individually
with GST, p53, and CoVa dsRNA or in combi-
nations as indicated. Cellular ATP levels were
assayed in the days after dsRNA treatment.
(B) Western blot analysis of p53 dsRNA (con-
trol) or CoVa + p53 dsRNA-treated cells with
an antibody against activated AMPK (a-
pAMPK). Actin was used as a loading control.
(C) Proliferation profile of S2 cells treated ei-
ther with GST dsRNA, p53 dsRNA, or CoVa
dsRNA or in different combinations as indi-
cated. In spite of the drop in ATP (shown in
[A]) and the increase in p-AMPK (shown in
[B]), the CoVa + p53 dsRNA-treated cells
show considerable rescue in their prolifera-
tion profile as compared with cells treated
with CoVa dsRNA alone.
(D) BrdU incorporation (red) in the eye disc.
Somatic clones doubly mutated for tend
and p53 (absence of green) show a rescue
in BrdU incorporation compared with clones
of tend alone (compare with Figures 1F and
1G).
(E) In eye discs with double mutant clones of
tend and p53, Cyclin E (red) expression re-
covers to wild-type levels.
(F–G0) SEM of adult eyes. (F and F0) Clones of
tend appear smooth. (G and G0) The smooth
eye phenotype of tend clones is partially res-
cued in double mutant clones of tend and
p53. Mutant clones are shown in higher mag-
nification in (F0) and (G0) for comparison.
(H) The genetic pathway linking CoVa func-
tion to Cyclin E in the regulation of the G1-S
transition during mitosis.
(I and J) A model for mitochondrial control of
the Cyclin E-mediated mitotic checkpoint
(see Discussion for details).G1 checkpoint activated upon loss of CoVa can be over-
ridden by the loss of AMPK, suggesting that AMPK acts
downstream of tend to enforce the checkpoint. As an
expected consequence of overriding a checkpoint, the
immediate rescue of the BrdU phenotype and Cyclin E
expression in the eye disc is more complete than the
rescue of the adult eye phenotype.
Biochemical analysis in mammalian cell lines has iden-
tified two pathways: one mediated by TOR (Inoki et al.,
2003), and the other mediated by p53 (Jones et al.,
2005), downstream of AMPK. Activation of AMPK can
lead to growth arrest by inhibiting TOR function (Inoki
et al., 2003). However, cells in somatic clones of dTOR
exhibit normal BrdU incorporation during larval eye de-
velopment (Figure 6N). This indicates that inhibition of
TOR primarily affects cell growth, but not cell prolifera-
tion, and is unlikely to be the target of AMPK in the path-
way regulating Cyclin E described here.
Recent studies by Jones et al. (2005) have shown that
high AMPK activity can also stabilize p53. We therefore
compared ATP levels and proliferation profiles of cells
doubly depleted for CoVa and p53 with those that are
singly depleted for each. No significant decrease in cel-lular ATP is seen in S2 cells treated withp53dsRNA, and,
as expected, cells treated with both CoVa and p53
dsRNA show a profile of ATP reduction comparable to
that seen for CoVa alone (Figure 7A). Furthermore, S2
cells doubly depleted for CoVa and p53 activate AMPK
as in CoVa dsRNA-treated cells (Figure 7B). Remark-
ably, in spite of the low ATP levels and the consequent
activation of AMPK, the p53 and CoVa doubly depleted
cells proliferate significantly better than cells depleted
for CoVa alone (Figure 7C). This suggests a role for
p53 downstream of CoVa and AMPK in the control of
the cell cycle. As in mammalian systems (Jones et al.,
2005), it is likely that AMPK activates p53 posttranscrip-
tionally, as we do not see a change in p53 RNA levels in
CoVa-depleted cells (data not shown). The involvement
of p53 in this pathway was then tested in vivo. p53 mu-
tant flies are homozygous viable and have wild-type
eyes (Sogame et al., 2003). When tend clones are gener-
ated in flies that are otherwise homozygous mutant for
p53, a remarkable rescue of the tend BrdU defect is ob-
served in the eye disc (Figure 7D). The loss of Cyclin E
expression is also rescued in the double mutant clones
(Figure 7E). Additionally, the double mutant combination
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851shows a partial rescue of the glossy eye phenotype (Fig-
ures 7G and 7G0) associated with tend clones (Figures
7F and 7F0). This shows that the checkpoint activated
in tend mutants can be overridden by mutations in
p53, and it implicates p53 as the downstream effector
of AMPK in controlling Cyclin E in this pathway. The ge-
netic pathway linking mitochondrial function to Cyclin E
is shown in Figure 7H.
Discussion
This study describes a mitotic checkpoint that is acti-
vated in periods of lowered mitochondrial function (Fig-
ures 7I and 7J). We show that a null mutation in CoVa,
a nuclear-encoded component of the mitochondrial
electron transport chain, lowers intracellular ATP to
about 40% of normal. This ATP level is sufficient to sup-
port cell survival, growth, and differentiation, and it al-
lows us to genetically dissect the pathway connecting
mitochondrial function to cell division. The 60% reduc-
tion in ATP levels in mutant cells activates the energy
sensor AMPK, presumably due to an increase in cellular
AMP levels. In turn, AMPK activates the cell cycle check-
point regulator p53 and brings about a cell cycle arrest
by reducing levels of the rate-limiting protein Cyclin E.
Although it might be assumed that mutations in mito-
chondrial proteins would cause a general slowdown of
all cellular processes, our results show that tend mutant
cells are remarkably healthy and are capable of differen-
tiation and morphogenesis. In the eye disc, tend mutant
cells adopt their appropriate fate, transcribe genes re-
lated to proliferation and differentiation control, and
are capable of extensive morphological changes, such
as projecting axons to their target regions in the brain.
The only cellular dysfunction that we have detected
upon the 60% drop in ATP levels in tend mutants is the
block in cell cycle. Furthermore, we did not observe
any increase in apoptosis in tend mutant cells, although
it is likely that other mitochondrial mutations that cause
a more precipitous drop in ATP levels would activate cell
death mechanisms. We conclude that a mechanism in-
volving Cyclin E operates to block the cell cycle specif-
ically at the G1-S transition point in response to a limiting
threshold in its ATP level (Figures 7I and 7J).
Cell division is an energy-intensive process, and inhi-
bition of the cell cycle by an ATP-dependent checkpoint
is critical. Checkpoints are surveillance mechanisms
that respond to stress and activate processes that main-
tain viability. AMPK and p53 are not required for regulat-
ing cell cycle progression under normal growth condi-
tions in wild-type flies. As a result, loss-of-function
mutations in either AMPKg or p53 have a wild-type eye
phenotype. However, AMPK and p53 do function to con-
trol the cell cycle in response to low ATP by triggering
downregulation of Cyclin E protein. As has been de-
scribed for other checkpoints, we were able to override
this cell cycle arrest. This was achieved by making dou-
ble mutant clones of tend and p53 or tend and AMPKg.
The result is a dramatic rescue of the BrdU incorporation
phenotype as well as Cyclin E expression in the double
mutant cells. Previous work has shown Drosophila p53
to have a role in irradiation-mediated cell death (Brodsky
et al., 2000; Sogame et al., 2003). In contrast, mamma-
lian p53 has been shown to have a function in both cellcycle and apoptosis. We demonstrate that Drosophila
p53 also functions in cell cycle arrest under conditions
of modest loss of metabolic function. It is likely that
the triggering of apoptotic pathways by irradiation re-
quires a higher threshold of p53 function. This notion
is consistent with work in mammalian systems in which
small changes in p53 levels or activity trigger a cell cycle
arrest. Moreover, as the levels increase the cells turn on
the apoptotic machinery (Vousden, 2000).
In addition to CoVa, we found that mutations in sev-
eral other mitochondrial proteins, primarily large and
small subunits of ribosomal proteins (mRpLs and
mRpSs), also show a BrdU incorporation block similar
to that seen in tend. While the details of the molecular
pathways affected in these other mutants remain to be
investigated, it is likely that these mutations affect the
translation of proteins encoded by the mitochondrial ge-
nome and as a result prevent the electron transport
chain from functioning optimally. Since multiple genes
encode proteins of the ribosomal subunits, their func-
tions may be redundant, and a mutation in any one com-
ponent may only partially reduce mitochondrial transla-
tion. However, not all mRp mutations show cell cycle
arrest (Frei et al., 2005; Galloni, 2003). We speculate
that when mutations are made in each mitochondrial
protein and in combinations, it will be possible to iden-
tify mechanisms that create a balance between cell pro-
liferation, cell growth, and cell death. Our in vivo obser-
vations of deprivation of mitochondrial function are
similar to the observations made in cell culture experi-
ments in which mouse embryonic fibroblasts are ex-
posed to different levels of glucose (Jones et al.,
2005). Whereas cells completely deprived of glucose
die, cells receiving 0.5 mM glucose show a p53-depen-
dent cell cycle arrest similar to that seen upon partial
ATP deprivation in our studies.
The downregulation of Cyclin E in response to mito-
chondrial dysfunction is posttranscriptional. It is not
yet clear whether this is due to reduced translation of
the Cyclin E transcript or accelerated degradation of
the Cyclin E protein. In S. cerevisiae, Cln3, a Cyclin crit-
ical for the G1-S transition, is regulated at the transla-
tional level in response to the absence of a fermentable
carbon source (Polymenis and Schmidt, 1997). A similar
mechanism could potentially provide a means of altering
Cyclin E protein levels without affecting other protein
products in the cell. On the other hand, several Ubiquitin
ligases, including Archipelago, Sina, and Ebi (Boulton
et al., 2000; Brumby et al., 2004; Moberg et al., 2001),
have been associated with normal Cyclin E degradation
during the cell cycle. However, in preliminary studies of
the kind that allowed us to identify AMPK and p53 as
downstream components of tend, we were unable to de-
tect a role for archipelago, sina, or ebi in this process.
This is not surprising since the Drosophila genome has
over 50 potential genes encoding members of the E3
Ubiquitin ligase complex (Ou et al., 2003). Finally, in
mammalian systems, p53-activated G1-S arrest in-
volves transcriptional activation of the CDK inhibitor
p21 (el-Deiry et al., 1993). The only known homolog of
the p27/p21 family of proteins in Drosophila is Dacapo,
which is not upregulated in tend mutant cells. Although,
no other p21-like gene has been identified, it remains
a possibility that a protein with low homology to p21 is
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852involved as a CDK inhibitor. In Figure 7, we have desig-
nated the missing component between p53 and Cyclin E
as X. Given the tools available inDrosophila, future mod-
ifier screens should reveal the identity of X.
An interesting finding from this work is that tend cells
are not compromised in their size. In fact, mutant cells
show a slight (13%) increase in size compared to their
wild-type counterparts. Previous work has shown that
AMPK activation inhibits TOR function, and it was there-
fore conceivable that the cell cycle arrest phenotype in
tend could be a consequence of a similar growth arrest.
Instead, our study shows that tend mutants have a
phenotype complementary to that of TOR. Cells mutant
for TOR are smaller in size and show normal BrdU incor-
poration, while tend cells are slightly larger than wild-
type and are affected in the G1-S transition step of cell
division.
This study is an in vivo demonstration of a mitochon-
drial regulation of a checkpoint blocking cell cycle pro-
gression. Activation of this regulatory mechanism to
block the cell cycle will allow a cell to weather a period
of energy deprivation by pausing in the cell cycle and re-
suming proliferation upon the return of energy sources.
Periods of energy insufficiency can be due to a variety
of reasons, including limited oxygen availability. Hypoxia
diminishes the cell’s oxidative phosphorylation capacity
and can cause cell cycle arrest in a number of species,
including Drosophila (DiGregorio et al., 2001) and
C. elegans (Padilla et al., 2002). Similarly, it has been sug-
gested that the ability of cells deep inside solid tumors to
withstand radiation as well as chemotherapy is due to
hypoxia-induced G1 arrest (Graeber et al., 1994; Kim
et al., 1997). It is tempting to speculate that cells could
use this mode of cell cycle arrest to their advantage dur-
ing normal development. Hematopoetic stem cells in the
bone marrow are distributed along a gradient of oxygen;
stem cells residing in more hypoxic conditions cycle
slowly, while proliferating progenitor cells are in nor-
moxic regions (Danet et al., 2003). It will be interesting
to determine in future studies if the cell cycle arrest ob-
served in stem cells utilizes pathways that we have de-
scribed here for CoVa.
Experimental Procedures
Stocks and Mutations
y w ey-flp; FRT82B males were mutagenized with 25 mM ethylme-
thanesulfonate (EMS) and crossed to y w ey-flp; FRT82B P[w+]cl-
R3/TM6B Tb, y+. Similar in function to a Minute cl-R3 is a cell-lethal
mutation (Newsome et al., 2000). Mosaic-eyed flies with an eye phe-
notype were crossed to balancer lines and maintained as stocks.
p5311-1B-1, P[SUP]SNF4AgKG00325, P[w+]mRpL4[k14608],
P[SUP]mRpL17[KG06809], P[w+]Pdsw[k10101], and TOR[DeltaP]
FRT40A were all from the Bloomington Stock Center. hs-cyclinEII
flies were a gift from Helena Richardson.
Molecular Mapping
To map the tend eye phenotype, we recombined a distal P element,
P[SUP]KG03257, at 87A4 onto the FRT chromosome carrying the
tendmutation by using standard meiotic recombination procedures.
The presence of tend and P[SUP]KG03257 was determined by
crossing with y w ey-flp; FRT82B P[w+]cl-R3/TM6B Tb, y+ and scor-
ing for the glossy eye phenotype. P[SUP]KG03257 carries a y+
marker, and the presence of the P element was determined by the
gray body color in an otherwise yellow background. The FRT82B
tend, P[SUP]KG03257 recombined chromosome was placed in
trans with the P element, P[GT1]BG01876, on 86F5. Recombinantsbetween the two P elements were isolated as white-eyed flies in
an otherwise red-eyed population. Again, the presence and absence
of tend was determined by making adult clones. The site of recom-
bination was mapped to an interval between SNPs that marked the
recombinant chromosome. Based on the location of the SNPs, the
map position of the phenotype was further refined to a region be-
tween 86F6 and 86F9.
Generation of Clones, Immunohistochemistry, and FACS
Adult eye clones were made by using flies of the genotype y w ey-flp;
FRT82B P[w+]cl-R3/TM6B Tb, y+. Mutant clones were marked by the
absence of pigmentation.
Larval clones were generated by using y w ey-flp; FRT82B Ubi-
GFP RpS3/TM6B Tb, y+ or hsp70-flp; FRT82B Ubi-GFP RpS3/
TM6B Tb, y+. Large clones that gave mutant cells a growth advan-
tage were made possible because of the ribosomal mutations
Rps3 or M on the wild-type chromosome. For the experiment shown
in Figure 5, clones were made with hsp70-flp; FRT82B Ubi-GFP/
TM6B Tb, y+.
The following antibodies were used: rat anti-BrdU (Abcam), rabbit
anti-Atonal (Y.N. Jan), rabbit anti-BarH1 (T. Kojima), guinea pig anti-
Cyclin E (T. Orr-Weaver), rat anti-Cyclin E and mouse anti-Cyclin E
(H. Richardson), mouse anti-Cyclin D (W. Du), mouse anti-Dacapo
(I. Hariharan), rat anti-Ci (R. Holmgren), mouse anti-GFP and rabbit
anti-GFP (Molecular Probes), rabbit anti-phospho-AMPKa (Thr-
172, 40H9) and rabbit anti-AMPKa (Cell Signaling), rat anti-elav,
mAb24B10, mouse anti-Cyclin A, mouse anti-Cyclin B, mouse anti-
Armadillo, mouse anti-Actin, mouse anti-Cut (Iowa Hybridoma Cen-
ter), and mouse anti-Lozenge (Lebestky et al., 2000).
Imaginal disc BrdU incorporation was carried out for 30 min or 2 hr
as described (de Nooij and Hariharan, 1995). Apoptotic cells were
identified by TUNEL labeling with an in situ cell death detection kit
(Roche).
Flow cytometric analysis was carried out as described (Neufeld
et al., 1998) on wing disc cells dispersed with Trypsin, stained with
Hoechst 33342 dye (Sigma), and sorted by using a Becton Dickinson
FACS Calibur Analytic Flow Cytometer.
Cell Culture, RNAi, and ATP Assay
To prepare dsRNA 500 bp of coding sequence for CoVa, p53, or GST
was PCR amplified with primers carrying a 50 T7 RNA polymerase
binding site. dsRNA was purified by using a Megascript RNAi kit
(Ambion) and was stored at 220ºC. Cells were treated with 20 mg
dsRNA individually or 20 mg each in combination. S2 cells seeded
to a density of 106 per well in 6-well plates were treated on the follow-
ing day with dsRNA as described (Clemens et al., 2000). The day of
dsRNA treatment is termed Day 0. The cells were split and reseeded
to a density of 106 on Day 2 and Day 5 after dsRNA treatment. Cells
were isolated each day from Day 2 to Day 8 for ATP, protein, and
RNA measurements. ATP measurements were carried out by using
a luciferin-luciferase-based ATP Assay kit (Calbiochem) and were
normalized to the cell number.
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